These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16600982)

  • 1. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
    Yeo W; Mo FK; Koh J; Chan AT; Leung T; Hui P; Chan L; Tang A; Lee JJ; Mok TS; Lai PB; Johnson PJ; Zee B
    Ann Oncol; 2006 Jul; 17(7):1083-9. PubMed ID: 16600982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
    Diouf M; Filleron T; Barbare JC; Fin L; Picard C; Bouché O; Dahan L; Paoletti X; Bonnetain F
    J Hepatol; 2013 Mar; 58(3):509-21. PubMed ID: 23178978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
    Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
    Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.
    Hammad AY; Robbins JR; Turaga KK; Christians KK; Gamblin TC; Johnston FM
    Ann Palliat Med; 2017 Jan; 6(1):26-35. PubMed ID: 28061532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
    Bonnetain F; Paoletti X; Collette S; Doffoel M; Bouché O; Raoul JL; Rougier P; Masskouri F; Barbare JC; Bedenne L
    Qual Life Res; 2008 Aug; 17(6):831-43. PubMed ID: 18618292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Lladó L; Virgili J; Figueras J; Valls C; Dominguez J; Rafecas A; Torras J; Fabregat J; Guardiola J; Jaurrieta E
    Cancer; 2000 Jan; 88(1):50-7. PubMed ID: 10618605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy.
    Park SH; Cho MS; Kim YS; Hong J; Nam E; Park J; Cho EK; Shin DB; Lee JH; Lee WK
    Qual Life Res; 2008 Mar; 17(2):207-14. PubMed ID: 18224458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role functioning is associated with survival in patients with hepatocellular carcinoma.
    Meier A; Yopp A; Mok H; Kandunoori P; Tiro J; Singal AG
    Qual Life Res; 2015 Jul; 24(7):1669-75. PubMed ID: 25502092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.
    Langendijk H; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Wouters M
    Radiother Oncol; 2000 Apr; 55(1):19-25. PubMed ID: 10788684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.
    Howell J; Pinato DJ; Ramaswami R; Arizumi T; Ferrari C; Gibbin A; Burlone ME; Guaschino G; Toniutto P; Black J; Sellers L; Kudo M; Pirisi M; Sharma R
    Oncotarget; 2017 May; 8(22):36161-36170. PubMed ID: 28212535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
    Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
    Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen compared to best supportive care in advanced hepatocelluar carcinoma: A retrospective matched-cohort study.
    Zeeneldin AA; Eid SM; Darweesh AD; Moneer MM; Saadeldin M
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):1-7. PubMed ID: 24565676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment.
    Shomura M; Kagawa T; Okabe H; Shiraishi K; Hirose S; Arase Y; Tsuruya K; Takahira S; Mine T
    BMC Cancer; 2016 Nov; 16(1):878. PubMed ID: 27835949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?
    Suzuki E; Chiba T; Ooka Y; Ogasawara S; Tawada A; Motoyama T; Kanogawa N; Saito T; Yoshikawa M; Yokosuka O
    World J Gastroenterol; 2015 Aug; 21(29):8888-93. PubMed ID: 26269678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.